MR-guidance in clinical reality: current treatment challenges and future perspectives S Corradini, F Alongi, N Andratschke, C Belka, L Boldrini, F Cellini, ... Radiation Oncology 14, 1-12, 2019 | 343 | 2019 |
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer M Guckenberger, N Andratschke, K Dieckmann, MS Hoogeman, M Hoyer, ... Radiotherapy and Oncology 124 (1), 11-17, 2017 | 333 | 2017 |
Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer M Guckenberger, N Andratschke, H Alheit, R Holy, C Moustakis, U Nestle, ... Strahlentherapie und Onkologie 190 (1), 26, 2014 | 295 | 2014 |
Update of human spinal cord reirradiation tolerance based on additional data from 38 patients C Nieder, AL Grosu, NH Andratschke, M Molls International Journal of Radiation Oncology* Biology* Physics 66 (5), 1446-1449, 2006 | 255 | 2006 |
Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies L Milas, Z Fan, NH Andratschke, KK Ang International Journal of Radiation Oncology* Biology* Physics 58 (3), 966-971, 2004 | 246 | 2004 |
Safety and efficacy of stereotactic body radiotherapy for stage I non–small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis M Guckenberger, M Allgäuer, S Appold, K Dieckmann, I Ernst, ... Journal of Thoracic Oncology 8 (8), 1050-1058, 2013 | 214 | 2013 |
Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients C Nieder, AL Grosu, NH Andratschke, M Molls International Journal of Radiation Oncology* Biology* Physics 61 (3), 851-855, 2005 | 199 | 2005 |
ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams L Wilke, N Andratschke, O Blanck, TB Brunner, SE Combs, AL Grosu, ... Strahlentherapie und Onkologie 195 (3), 193-198, 2019 | 195 | 2019 |
Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study CG Rusthoven, M Yamamoto, D Bernhardt, DE Smith, D Gao, T Serizawa, ... JAMA oncology 6 (7), 1028-1037, 2020 | 188 | 2020 |
Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention N Andratschke, J Maurer, M Molls, KR Trott Radiotherapy and Oncology 100 (2), 160-166, 2011 | 179 | 2011 |
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy KK Ang, NH Andratschke, L Milas International Journal of Radiation Oncology* Biology* Physics 58 (3), 959-965, 2004 | 175 | 2004 |
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—a pooled analysis of the German working group “stereotactic radiotherapy” J Rieber, J Streblow, L Uhlmann, M Flentje, M Duma, I Ernst, O Blanck, ... Lung Cancer 97, 51-58, 2016 | 171 | 2016 |
Radiotherapy for high-grade gliomas C Nieder, N Andratschke, N Wiedenmann, R Busch, AL Grosu, M Molls Strahlentherapie und Onkologie 180 (7), 401, 2004 | 168 | 2004 |
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS … S Peters, E Felip, U Dafni, C Belka, M Guckenberger, A Irigoyen, E Nadal, ... Lung cancer 133, 83-87, 2019 | 162 | 2019 |
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver … N Andratschke, H Alheid, M Allgäuer, G Becker, O Blanck, ... BMC cancer 18, 1-11, 2018 | 152 | 2018 |
Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary … T Pyka, RA Bundschuh, N Andratschke, B Mayer, HM Specht, L Papp, ... Radiation oncology 10, 1-9, 2015 | 149 | 2015 |
Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure N Andratschke, F Zimmermann, E Boehm, S Schill, C Schoenknecht, ... Radiotherapy and Oncology 101 (2), 245-249, 2011 | 143 | 2011 |
Current status of angiogenesis inhibitors combined with radiation therapy C Nieder, N Wiedenmann, N Andratschke, M Molls Cancer treatment reviews 32 (5), 348-364, 2006 | 139 | 2006 |
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small … M Guckenberger, RJ Klement, M Allgäuer, S Appold, K Dieckmann, I Ernst, ... Radiotherapy and Oncology 109 (1), 13-20, 2013 | 135 | 2013 |
Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy M Guckenberger, RJ Klement, M Allgäuer, N Andratschke, O Blanck, ... Radiotherapy and Oncology 118 (3), 485-491, 2016 | 132 | 2016 |